SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-117740
Filing Date
2020-10-23
Accepted
2020-10-23 16:39:00
Documents
9
Period of Report
2020-10-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2033857d7_8k.htm 8-K 26665
2 EXHIBIT 1.1 tm2033857d7_ex1-1.htm EX-1.1 305911
3 EXHIBIT 5.1 tm2033857d7_ex5-1.htm EX-5.1 12003
4 EXHIBIT 99.1 tm2033857d7_ex99-1.htm EX-99.1 9442
5 EXHIBIT 99.2 tm2033857d7_ex99-2.htm EX-99.2 10459
6 GRAPHIC tm2033857d7_ex1-1img001.jpg GRAPHIC 9191
7 GRAPHIC tm2033857d7_ex5-1img001.jpg GRAPHIC 5484
8 GRAPHIC tm2033857d7_ex5-1img002.jpg GRAPHIC 1016
9 GRAPHIC tm2033857d7_ex5-1img003.jpg GRAPHIC 1089
  Complete submission text file 0001104659-20-117740.txt   389319
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38596 | Film No.: 201258152
SIC: 2836 Biological Products, (No Diagnostic Substances)